Magnera Unveils PFAS-Free Liquid Barrier Technology in Nonwovens Industry Webinar

Reuters
Feb 10
Magnera Unveils PFAS-Free Liquid Barrier Technology in Nonwovens Industry Webinar

Magnera Corporation will host an exclusive webinar in partnership with Nonwovens Industry, focusing on its Next-Gen Liquid Barrier Technology for healthcare and other critical applications. The event, titled "Magnera Corporation Redefining Fluid Protection for Healthcare and Beyond," is scheduled for March 4 at 10:00 a.m. ET. The session will highlight Magnera's innovative, PFAS-free fluid barrier solutions designed to meet demanding protection and comfort standards in industries such as healthcare and industrial safety. Attendees will learn about the technology’s benefits for safety, sustainability, and regulatory compliance. To register for the webinar, visit: https://event.on24.com/wcc/r/5230631/98B9BAE13145B724F453D3C82E4CAFA0?partnerref=magnera-promo. For more details on the technology, see: Magnera Introduces Innovative Solution for Healthcare and Beyond, Focusing on Safety and Sustainability.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Magnera Corporation published the original content used to generate this news brief on February 10, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10